Reduced circulating 20-hydroxyeicosatetraenoic acid and ACE2 in acute coronary syndrome with exploratory cell-based observations. [PDF]
Čiapienė I +8 more
europepmc +1 more source
CYP3A4, CYP3A5, and CYP4F2 Polymorphisms and Bleeding Risk in Ticagrelor-Based Dual Antiplatelet Therapy. [PDF]
Dakić S +13 more
europepmc +1 more source
Pharmacogenomic landscape in Thailand: Array-based profiling and EMR-linked medication exposure. [PDF]
Pasookhush P +6 more
europepmc +1 more source
Explainable Artificial Intelligence Unravels the Possible Distinct Roles of VKORC1 and CYP2C9 in Predicting Warfarin Anticoagulation Control. [PDF]
Sridharan K, Sivaramakrishnan G.
europepmc +1 more source
Long-term health outcomes and comorbidities in cytochrome P450 oxidoreductase (POR) deficiency: a scoping review of evidence and knowledge gaps. [PDF]
Kouri C, Thirukkumar A, Flück CE.
europepmc +1 more source
Beyond the Very Important Pharmacogenes (VIPs): Uncovering Shadow Pharmacogenes in the Human Drug Response Network. [PDF]
de Melo NC +5 more
europepmc +1 more source
Clinically Relevant Pharmacogenomic Variant Frequencies in Kazakh, Russian, and Uzbek Population Groups Residing in Kazakhstan. [PDF]
Zhaniyazov Z +11 more
europepmc +1 more source
Gender-Specific Associations of CYP4F2 (rs1558139) Gene Polymorphism and Serum Levels in Early and Exudative Age-Related Macular Degeneration. [PDF]
Vilkeviciute A +6 more
europepmc +1 more source
The complex lipidome as a driver of tissue-specific pathology in adrenoleukodystrophy. [PDF]
Kemp S, Engelen M, Jaspers YRJ.
europepmc +1 more source
Derivation and Validation of a Genotype- Guided Warfarin Dosing Model in a Mixed Arab Population. [PDF]
Fahmi AM +5 more
europepmc +1 more source

